Development of a new Cox model for predicting long-term survival in hepatitis cirrhosis patients underwent transjugular intrahepatic portosystemic shunts

doi:10.4240/wjgs.v16.i2.491

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1896)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

980

Figures (1-6)

183

Tables (1-3)

168

Sum=1415

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

118

Download

299

Sum=417

Feb 27, 2024 (publication date) through Jan 17, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Feb 27, 2024; 16(2): 491-502
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.491

Full Size Figure Download Figure

Figure 3 Nomogram of the newly developed Cox model for predicting 6-year survival after transjugular intrahepatic portosystemic shunt implantation in patients with hepatitis cirrhosis. ICGR15: Indocyanine green retention rate at 15 min; PVP: Portal venous pressure; Tbil: Total bilirubin.

Citation: Lv YF, Zhu B, Meng MM, Wu YF, Dong CB, Zhang Y, Liu BW, You SL, Lv S, Yang YP, Liu FQ. Development of a new Cox model for predicting long-term survival in hepatitis cirrhosis patients underwent transjugular intrahepatic portosystemic shunts. World J Gastrointest Surg 2024; 16(2): 491-502
URL: https://www.wjgnet.com/1948-9366/full/v16/i2/491.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i2.491